Taiho Oncology, Inc.
Terri Washington is an experienced medical affairs professional currently serving as Senior Director of Medical Affairs at Taiho Oncology, Inc. since August 2016. Prior to this role, Terri held the position of Director of Medical Affairs at Peregrine Pharmaceuticals for a brief period in early 2016 and at NantKwest from September 2015 to December 2015. Additionally, Terri was a Director at Synta Pharmaceuticals from October 2012 to September 2015, contributing to significant advancements in the medical field throughout these roles.
This person is not in the org chart
Taiho Oncology, Inc.
2 followers
The mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer, their families and their caregivers. The company specializes in the development of orally administered anti-cancer agents and markets these medicines for a range of tumor types in the U.S. Taiho Oncology’s growing pipeline of selectively targeted anti-cancer agents is led by a world-class clinical development organization. Taiho Oncology is a subsidiary of Taiho Pharmaceutical Co., Ltd. which is part of Otsuka Holdings Co., Ltd. Taiho Oncology is headquartered in Princeton, New Jersey and oversees its parent company’s European and Canadian operations, which are located in Zug, Switzerland and Oakville, Ontario, Canada. For more information, visit www.taihooncology.com